• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

棘白菌素类药物卡泊芬净和米卡芬净(而非阿尼芬净)对白色念珠菌和都柏林念珠菌临床分离株具有矛盾的生长效应。

Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis.

作者信息

Fleischhacker M, Radecke C, Schulz B, Ruhnke M

机构信息

Department of Internal Medicine, Div. Oncology and Hematology, Charité Universitätsmedizin Berlin, Charité Campus Mitte, Charitéplatz 1, 10117 Berlin, Germany.

出版信息

Eur J Clin Microbiol Infect Dis. 2008 Feb;27(2):127-31. doi: 10.1007/s10096-007-0411-4. Epub 2007 Dec 4.

DOI:10.1007/s10096-007-0411-4
PMID:18057972
Abstract

OBJECTIVES

To analyze the effects of a high concentration of three antifungal substances, the echinocandins anidulafungin, caspofungin, and micafungin, on the growth of Candida spp.

METHODS

The growth of 127 C. dubliniensis isolates and 103 C. albicans isolates cultured in medium containing anidulafungin, caspofungin, or micafungin was analyzed using a broth microdilution test according to the guidelines of the CLSI M27-A2 [NCCLS (1997), Wayne, PA]. The final concentrations of all three echinocandins ranged from 0.125 to 64 microg/L.

RESULTS

The different effects of these three antifungal substances on C. albicans cells in comparison to C. dubliniensis cells were quite distinct. When both Candida species were grown in the presence of anidulafungin only a trailing effect was observed. Micafungin induced an Eagle effect in C. dubliniensis only (63%), while caspofungin induced this effect in the majority of C. dubliniensis isolates (90%) and in only a few C. albicans isolates (14%).

CONCLUSIONS

Based on our observations, anidulafungin has effects that are different from the ones produced by micafungin and caspofungin. Whether this different response to high concentrations of echinocandins is based on genetic or phenotypic differences between C. albicans and C. dubliniensis has to be determined in future experiments.

摘要

目的

分析三种高浓度抗真菌物质(棘白菌素类的阿尼芬净、卡泊芬净和米卡芬净)对念珠菌属生长的影响。

方法

根据CLSI M27 - A2 [NCCLS(1997年),宾夕法尼亚州韦恩市]指南,采用肉汤微量稀释法分析在含有阿尼芬净、卡泊芬净或米卡芬净的培养基中培养的127株都柏林念珠菌分离株和103株白色念珠菌分离株的生长情况。所有三种棘白菌素的终浓度范围为0.125至64μg/L。

结果

与都柏林念珠菌细胞相比,这三种抗真菌物质对白色念珠菌细胞的不同作用相当明显。当两种念珠菌在仅存在阿尼芬净的情况下生长时,仅观察到拖尾效应。米卡芬净仅在都柏林念珠菌中诱导伊格尔效应(63%),而卡泊芬净在大多数都柏林念珠菌分离株(90%)和少数白色念珠菌分离株(14%)中诱导这种效应。

结论

根据我们的观察,阿尼芬净的作用与米卡芬净和卡泊芬净不同。白色念珠菌和都柏林念珠菌对高浓度棘白菌素的这种不同反应是基于基因差异还是表型差异,必须在未来的实验中确定。

相似文献

1
Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis.棘白菌素类药物卡泊芬净和米卡芬净(而非阿尼芬净)对白色念珠菌和都柏林念珠菌临床分离株具有矛盾的生长效应。
Eur J Clin Microbiol Infect Dis. 2008 Feb;27(2):127-31. doi: 10.1007/s10096-007-0411-4. Epub 2007 Dec 4.
2
In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.念珠菌属侵袭性分离株对阿尼芬净、卡泊芬净和米卡芬净的体外敏感性:六年全球监测
J Clin Microbiol. 2008 Jan;46(1):150-6. doi: 10.1128/JCM.01901-07. Epub 2007 Nov 21.
3
Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin.用于棘白菌素类药物阿尼芬净、卡泊芬净和米卡芬净抗真菌药敏试验的 Sensititre YeastOne 比色法抗真菌药敏板的临床评估。
J Clin Microbiol. 2008 Jul;46(7):2155-9. doi: 10.1128/JCM.00493-08. Epub 2008 May 7.
4
Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.采用欧洲抗菌药物敏感性试验委员会和临床实验室标准协会肉汤微量稀释法评估意大利分离的念珠菌属菌株对棘白菌素类药物的敏感性。
BMC Microbiol. 2015 May 20;15:106. doi: 10.1186/s12866-015-0442-4.
5
Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species.比较欧洲抗菌药物敏感性试验委员会 (EUCAST) 和 Etest 方法与 CLSI 肉汤微量稀释法检测念珠菌属对棘白菌素类药物敏感性。
J Clin Microbiol. 2010 May;48(5):1592-9. doi: 10.1128/JCM.02445-09. Epub 2010 Mar 24.
6
Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp.棘白菌素类药物和念珠菌属的野生型 MIC 分布和流行病学折点值
J Clin Microbiol. 2010 Jan;48(1):52-6. doi: 10.1128/JCM.01590-09. Epub 2009 Nov 18.
7
Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Candida species to anidulafungin, caspofungin, and micafungin.利用流行病学截断值来检测 9 年来念珠菌属对安尼鲁单抗、卡泊芬净和米卡芬净敏感性的变化趋势。
J Clin Microbiol. 2011 Feb;49(2):624-9. doi: 10.1128/JCM.02120-10. Epub 2010 Dec 8.
8
Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia.卡泊芬净、米卡芬净和阿尼芬净对已萌发和未萌发的曲霉分生孢子的体外药效学比较
Antimicrob Agents Chemother. 2008 Jan;52(1):321-8. doi: 10.1128/AAC.00699-07. Epub 2007 Oct 15.
9
Paradoxical growth of Candida dubliniensis does not preclude in vivo response to echinocandin therapy.杜波依斯念珠菌的反常生长并不排除对棘白菌素类治疗的体内反应。
Antimicrob Agents Chemother. 2009 Dec;53(12):5297-9. doi: 10.1128/AAC.00980-09. Epub 2009 Sep 28.
10
Echinocandin susceptibility testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 standard procedures: analysis of the influence of bovine serum albumin supplementation, storage time, and drug lots.棘白菌素类药敏试验检测 Candida spp. 使用 EUCAST EDef 7.1 和 CLSI M27-A3 标准程序:牛血清白蛋白添加、储存时间和药物批次的影响分析。
Antimicrob Agents Chemother. 2011 Apr;55(4):1580-7. doi: 10.1128/AAC.01364-10. Epub 2011 Jan 18.

引用本文的文献

1
Genomic and Molecular Identification of Genes Contributing to the Caspofungin Paradoxical Effect in .棘白菌素类药物悖论效应相关基因的基因组和分子鉴定
Microbiol Spectr. 2022 Oct 26;10(5):e0051922. doi: 10.1128/spectrum.00519-22. Epub 2022 Sep 12.
2
Early Empirical Anidulafungin Reduces the Prevalence of Invasive Candidiasis in Critically Ill Patients: A Case-control Study.早期经验性使用阿尼芬净可降低重症患者侵袭性念珠菌病的患病率:一项病例对照研究。
J Crit Care Med (Targu Mures). 2022 May 12;8(2):89-99. doi: 10.2478/jccm-2022-0006. eCollection 2022 Apr.
3
Adaptation of the emerging pathogenic yeast to high caspofungin concentrations correlates with cell wall changes.

本文引用的文献

1
Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differences.棘白菌素对念珠菌属的体外矛盾效应:棘白菌素特异性及念珠菌属相关差异的证据
Antimicrob Agents Chemother. 2007 Jun;51(6):2257-9. doi: 10.1128/AAC.00095-07. Epub 2007 Apr 16.
2
The echinocandins.棘白菌素类
Pharmacotherapy. 2007 Mar;27(3):369-88. doi: 10.1592/phco.27.3.369.
3
Candida albicans and Candida dubliniensis respond differently to echinocandin antifungal agents in vitro.白色念珠菌和都柏林念珠菌在体外对棘白菌素类抗真菌药物的反应不同。
新型致病性酵母对高浓度卡泊芬净的适应性与细胞壁变化有关。
Virulence. 2021 Dec;12(1):1400-1417. doi: 10.1080/21505594.2021.1927609.
4
Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Species.卡泊芬净、米卡芬净、阿尼芬净及新型棘白菌素瑞扎芬净对[具体物种]的矛盾生长和拖尾效应的相对频率
J Fungi (Basel). 2020 Aug 17;6(3):136. doi: 10.3390/jof6030136.
5
Antifungal Susceptibility Testing: Current Approaches.抗真菌药物敏感性测试:当前方法。
Clin Microbiol Rev. 2020 Apr 29;33(3). doi: 10.1128/CMR.00069-19. Print 2020 Jun 17.
6
Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal.血流感染中的抗真菌耐药性与耐受性:酵母-宿主-抗真菌三联体
Microorganisms. 2020 Jan 22;8(2):154. doi: 10.3390/microorganisms8020154.
7
Pharmacokinetics of Caspofungin in Critically Ill Patients in Relation to Liver Dysfunction: Differential Impact of Plasma Albumin and Bilirubin Levels.卡泊芬净在肝功能障碍的危重症患者中的药代动力学:血浆白蛋白和胆红素水平的差异影响。
Antimicrob Agents Chemother. 2019 May 24;63(6). doi: 10.1128/AAC.02466-18. Print 2019 Jun.
8
Treatment of Invasive Candidiasis: A Narrative Review.侵袭性念珠菌病的治疗:一篇叙述性综述。
J Fungi (Basel). 2018 Aug 16;4(3):97. doi: 10.3390/jof4030097.
9
Detection and Investigation of Eagle Effect Resistance to Vancomycin in With an ATP-Bioluminescence Assay.采用ATP生物发光法检测和研究万古霉素的鹰效应耐药性
Front Microbiol. 2018 Jul 2;9:1420. doi: 10.3389/fmicb.2018.01420. eCollection 2018.
10
Recent Insights into the Paradoxical Effect of Echinocandins.棘白菌素矛盾效应的最新见解
J Fungi (Basel). 2017 Dec 28;4(1):5. doi: 10.3390/jof4010005.
Antimicrob Agents Chemother. 2007 May;51(5):1882-4. doi: 10.1128/AAC.01525-06. Epub 2007 Feb 16.
4
Once-weekly micafungin therapy is as effective as daily therapy for disseminated candidiasis in mice with persistent neutropenia.对于持续性中性粒细胞减少的小鼠,每周一次的米卡芬净治疗在播散性念珠菌病的治疗效果上与每日治疗相当。
Antimicrob Agents Chemother. 2007 Mar;51(3):968-74. doi: 10.1128/AAC.01337-06. Epub 2006 Dec 28.
5
Antifungal agents: mode of action in yeast cells.抗真菌剂:在酵母细胞中的作用方式。
Rev Esp Quimioter. 2006 Jun;19(2):130-9.
6
Echinocandins in the management of invasive fungal infections, part 1.棘白菌素类药物在侵袭性真菌感染治疗中的应用,第1部分。
Am J Health Syst Pharm. 2006 Sep 15;63(18):1693-703. doi: 10.2146/ajhp050464.p1.
7
Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin.在高于最低抑菌浓度(矛盾效应)的浓度下,念珠菌通过增加细胞壁几丁质而逃避卡泊芬净的抑制作用;卡泊芬净抑制β-1,6-葡聚糖合成的证据。
Antimicrob Agents Chemother. 2006 Sep;50(9):3160-1. doi: 10.1128/AAC.00563-06.
8
Molecular fingerprinting methods for the discrimination between C. albicans and C. dubliniensis.用于区分白色念珠菌和都柏林念珠菌的分子指纹图谱方法。
Oral Dis. 2006 May;12(3):242-53. doi: 10.1111/j.1601-0825.2005.01189.x.
9
Assessment of the paradoxical effect of caspofungin in therapy of candidiasis.卡泊芬净治疗念珠菌病时矛盾效应的评估。
Antimicrob Agents Chemother. 2006 Apr;50(4):1293-7. doi: 10.1128/AAC.50.4.1293-1297.2006.
10
International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.欧盟CAST和CLSI M27 - A2肉汤微量稀释法检测念珠菌属对氟康唑、伊曲康唑、泊沙康唑和伏立康唑药敏的国际多中心比较
J Clin Microbiol. 2005 Aug;43(8):3884-9. doi: 10.1128/JCM.43.8.3884-3889.2005.